Hypofractionated radiotherapy for breast cancer including risk-adapted boost: Update on tolerance and efficacy of an accelerated START a regime

Stefan Janssen, Christoph Glanzmann, Stephanie Lang, Sarah Verlaan, Tino Streller, Claudia Linsenmeier, Dirk Rades, Gabriela Studer*

*Korrespondierende/r Autor/-in für diese Arbeit
6 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Hypofractionated radiotherapy for breast cancer including risk-adapted boost: Update on tolerance and efficacy of an accelerated START a regime“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medicine and Dentistry